LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

A new study led by University of Cincinnati Cancer Center researchers details how the accumulation of copper helps clear cell renal cell carcinoma (ccRCC)—the most common kidney cancer—grow and ...

Now, doctors at the Dana-Farber Cancer Institute are using a new F-D-A approved drug to help patients fight kidney cancer.

A decade ago, stage four kidney cancer had a survival rate of about a year. Today, advancements in treatment have ...

“Hopefully the time will come where patient, even with stage four kidney cancer, we can tell them, look, you have 50-50 chance of cure,” said Choueiri. In the past two years, Stravin’s cancer has not ...

A new study led by University of Cincinnati Cancer Center researchers details how the accumulation of copper helps clear cell renal cell carcinoma (ccRCC) -; the most common kidney cancer -; grow and ...

Alana Baird, a full time nurse at Princeton General Hospital, was recently diagnosed with advanced kidney cancer. On Friday, ...

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients ...

Pharmac has decided to fund lenvatinib from 1 December 2024 for people with some types of thyroid, liver, and kidney cancer. Lenvatinib (branded as Lenvima) stops the number of cancer cells from ...

People with some types of thyroid and liver cancer are getting free access to a targeted treatment for the first time, with ...